SpectraCure AB (publ) (FRA:2OK)
Germany · Delayed Price · Currency is EUR 0.0057
+0.0003 (5.56%)
Last updated: Dec 1, 2025, 8:20 AM CET
SpectraCure AB Company Description
SpectraCure AB (publ) engages in the development of cancer treatment system.
It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer.
The company was incorporated in 2003 and is based in Lund, Sweden.
SpectraCure AB (publ)
| Country | Sweden |
| Founded | 2003 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 16 |
| CEO | Johannes Swartling |
Contact Details
Address: Gasverksgatan 1 Lund, 222 29 Sweden | |
| Phone | 46 46 16 20 70 |
| Website | spectracure.com |
Stock Details
| Ticker Symbol | 2OK |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Johannes Swartling | Chief Executive Officer |
| Henrik Ljung | Chief Financial Officer |